>>8464812 pb
big pharma, shady banks, shady people
At that same time, we also announced that through the agreement with CEPI, GSK would provide its adjuvant technology to the University of Queensland, Australia, which has an existing partnership with CEPI to develop a “molecular clamp” vaccine platform, intended to enable targeted and rapid vaccine production against multiple viral pathogens. CEPI has extended this funding to work on a COVID-19 vaccine candidate, and access to the GSK adjuvant technology will now support this early stage research.
We have since announced a new collaboration with Clover Biopharmaceuticals, a China based global clinical-stage biotechnology company focused on developing novel and transformative biologic therapies. We will provide Clover with our pandemic adjuvant system for further evaluation of their coronavirus vaccine candidate. Having one of the largest in-house, commercial-scale cGMP biomanufacturing capabilities in China, Clover could potentially rapidly scale-up and produce large-quantities of a new coronavirus vaccine.
https://www.gsk.com/en-gb/media/resource-centre/our-contribution-to-the-fight-against-2019-ncov/